Literature DB >> 22493396

Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy.

Mikio Kawamura1, Susumu Saigusa, Yuji Toiyama, Koji Tanaka, Yoshinaga Okugawa, Junichiro Hiro, Keiichi Uchida, Yasuhiko Mohri, Yasuhiro Inoue, Masato Kusunoki.   

Abstract

BACKGROUND: Metastasis associated in colon cancer 1 (MACC1) is a recently identified gene that plays a key role in regulating hepatocyte growth factor-MET signaling. In this study, we demonstrated the correlation and the clinical significance of MACC1 and MET expression in rectal cancer patients treated with chemoradiotherapy (CRT) followed by surgery.
MATERIALS AND METHODS: The expression of MACC1 and MET mRNA in residual cancer cells from 52 patients after CRT was determined by quantitative real-time polymerase chain reaction. Protein expression was also investigated by immunohistochemical staining.
RESULTS: MACC1 and MET expressions were positively correlated. Furthermore, these proteins were also co-expressed in immunohistochemical analyses. High expression of MACC1 or MET was associated with reduced relapse-free survival and the prognosis was worse when both genes were highly expressed.
CONCLUSION: Evaluation of MACC1 and MET expression may be useful for predicting prognosis in patients with rectal cancer treated with CRT followed by surgery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493396

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.

Authors:  Manisha Juneja; Katharina Ilm; Peter M Schlag; Ulrike Stein
Journal:  Mol Oncol       Date:  2013-06-06       Impact factor: 6.603

2.  Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer.

Authors:  Lan Guo; Wanggui Lu; Xuan Zhang; Dixian Luo; Hongwen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Positive MACC1 expression correlates with invasive behaviors and postoperative liver metastasis in colon cancer.

Authors:  Yunfei Ge; Xiangrui Meng; Yong Zhou; Jianliang Zhang; Yinlu Ding
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer.

Authors:  Zhiqiang Wang; Zhi Li; Chen Wu; Yonggong Wang; Yang Xia; Liang Chen; Quan Zhu; Yijiang Chen
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

5.  Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer.

Authors:  Zhiqiang Wang; Ming Cai; Yuan Weng; Fang Zhang; Dong Meng; Jun Song; Huan Zhou; Zongtao Xie
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-28       Impact factor: 4.553

6.  MACC1 overexpression and survival in solid tumors: a meta-analysis.

Authors:  Gang Wang; Zhixuan Fu; Dechuan Li
Journal:  Tumour Biol       Date:  2014-10-19

7.  Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.

Authors:  Carsten Hagemann; Steffen Fuchs; Camelia M Monoranu; Pia Herrmann; Janice Smith; Tim Hohmann; Urszula Grabiec; Almuth F Kessler; Faramarz Dehghani; Mario Löhr; Ralf-Ingo Ernestus; Giles H Vince; Ulrike Stein
Journal:  Neuro Oncol       Date:  2013-11-11       Impact factor: 12.300

8.  c-MET inhibition enhances the response of the colorectal cancer cells to irradiation in vitro and in vivo.

Authors:  Yitao Jia; Guangyao Dai; Jinxi Wang; Xing Gao; Zhaolong Zhao; Zhihui Duan; Bin Gu; Weiguang Yang; Jianhua Wu; Yingchao Ju; Mingxia Wang; Zhongxin Li
Journal:  Oncol Lett       Date:  2016-03-03       Impact factor: 2.967

Review 9.  Prognostic Value of MACC1 in Digestive System Neoplasms: A Systematic Review and Meta-Analysis.

Authors:  Zhenzhen Wu; Rui Zhou; Yuqi Su; Li Sun; Yulin Liao; Wangjun Liao
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

Review 10.  Future directions for the early detection of colorectal cancer recurrence.

Authors:  Avery S Walker; Eric K Johnson; Justin A Maykel; Alex Stojadinovic; Aviram Nissan; Bjorn Brucher; Bradley J Champagne; Scott R Steele
Journal:  J Cancer       Date:  2014-03-16       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.